SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-17-003481
Filing Date
2017-06-05
Accepted
2017-06-05 21:56:57
Documents
1
Period of Report
2017-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4_spiegel060517.html 4  
1 OWNERSHIP DOCUMENT f4_spiegel060517.xml 4 5544
  Complete submission text file 0001171843-17-003481.txt   6904
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GERON CORPORATION 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address
Spiegel Robert J. (Reporting) CIK: 0001492256 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33609 | Film No.: 17892942